Correlation between Perception with The Needs of Structured Education for Psoriasis Patients during The Pandemic of COVID-19

Dewi Purnama Sari; Alfrina Hany; Magdalena Ayu  Christanti; Aura Tasya  Amalia

doi:10.21776/ub.jik.2022.010.01.3

Authors

Dewi Purnama Sari Nursing Department, Faculty of Health Sciences, University of Brawijaya
Alfrina Hany Nursing Department, Faculty of Health Sciences, University of Brawijaya
Magdalena Ayu Christanti Nursing Department, Faculty of Health Sciences, University of Brawijaya
Aura Tasya Amalia Nursing Department, Faculty of Health Sciences, University of Brawijaya

DOI:

https://doi.org/10.21776/ub.jik.2022.010.01.3

Keywords:

Psoriasis, Perception, Structured education

Abstract

The number of psoriasis patients visiting the health services during the COVID 19 pandemic is decreasing. Meanwhile, routine control is needed to maintain the prognosis education of psoriasis. The patient is suspected of having frequent problems and flares at home. Therefore, it is necessary to study the perception in assessing the need for structured education in a group of psoriasis patients. This study aimed to determine the correlation between perception with the need for structured education. Twenty psoriasis patients at General Hospital Dr. Saiful Anwar Malang were interviewed by telephone. The independent data consisted of patient perception (B-IPQ) of psoriasis, while the dependent data consisted of the need for structured education. Bivariate data showed the correlation between perception (B-IPQ) with the need for structured education, indicated by a p-value = 0.05. In conclusion, this study's perception (B-IPQ) level significantly correlates with the need for structured education. Promoting health education among people with psoriasis is essential to create a good perception of this diagnosis.

References

Badan Mutu Pelayanan Kesehatan. (2020). Kumpulan Referensi Layanan Kesehatan Esensial Pada Masa Pandemi Badan Mutu Pelayanan Kesehatan. http://badanmutu.or.id/2020/09/02/kumpulan-referensi-layanan-kesehatan-esensial-pada-masa-pandemi/.
Bartholomew, L.K., Parcel, G.S., Kok, G., and Gottlieb, N. H. (2006). Intervention Mapping Step 1: Needs Assessments. in Planning Health Promotion Programs: An Intervention Mapping Approach, pp. 193–250, Jossey-Bass, San Francisco, Calif, USA.
Gudjonsson, JE., Elder, JT. (2012). Psoriasis: General Medicine. Wolff, K., Goldsmith, LA., Katz (8nd ed., pp. 197-230 2). New York. Mc Grew Hill.
International Psoriasis Council. (2020). Statement on the Coronavirus (COVID-19) Outbreak, March 11. https://www.psoriasiscouncil.org/blog/Statement-on-COVID-19-and-Psoriasis.htm.
Jacobson, C.C., & Kimball, A. B. (2004). Rethinking the Psoriasis Area and
Severity Index: The Impact of the Area Should be Increased. British Journal of
Dermatology, 151(2), 381–387. https://doi.org/10.1111/j.1365-2133.2004.06035.x.
Javitz, HS., Ward, MM., Farber, E. Nail, L, Vallow, SG. (2002). Psoriatic Arthritis in the United States. J Am Acad Dermatol, 46, 850-860.
Kelompok Studi Psoriasis Indonesia Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia. (2014). Pedoman Tatalaksana Psoriasis dan Informed Consent.
Krisnarto, E., Novitasari, A., & Aulirahma, D. M. (2016). Faktor Prediktor Kualitas Hidup Pasien Psoriasis. Jurnal Unimus, 49, 43–51.
https://jurnal.unimus.ac.id/index.php/kedokteran/article/view/2584/2434.
Lebwohl, M., Rivera-Oyola, R., Murrell, DF. (2020). Should Biologics for Psoriasis.
Be Interrupted in the Era of COVID-19? J Amer Acad Dermatol, in press.
Medicinsk Teknologivurdering. (2009). Sundhedsstyrelsen, Monitorering & Medicinsk Teknolo-givurdering. Patientuddannelse—en Medicinsk Teknologivur-Dering, 11, 3. Odense Universitet Hospital.
Skarpathiotakis, M., Fairlie, C., & Ryan, S. (2006). Specialized education for patients with psoriasis: a patient survey on its value and effectiveness. Dermatology Nursing, 18(4), 358–361.
National Psoriasis Foundation. National Psoriasis Foundation Benchmark Survey. (2006). http:// www.psoriasis.org/files/pdfs/press/npfsurvey.pdf.
Price, KN., Frew, JW., Hsiao, JL., MD., Vivian., Y., Shi VY. (2020). COVID-19 and Immunomodulator/ Immunosuppressant Use in Dermatology. JAAD. Available from https://doi.org/10.1016/j.jaad.2020.03.046.
Reich K, Ortonne JP, Gottlieb AB. (2012). Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension. Br J Dermatol. 167(1): 180–190.
Shanshal M. Is the Coronavirus (COVID 19) (2020). Pandemic an Indication to temporarily Modify Dermatology Management Plans? Journal of Drugs in Dermatology April; 19(4): 436-7.
Tim Satgas Covid-19 PERDOSKI. (2020). Pandemi Covid-19 dan Implikasinya
Terhadap Praktik Dermatologi dan Venereologi di Indonesia. Pengurus Pusat PERDOSKI.